Vor Biopharma, Inc. (VOR)
13.55
+0.24
(+1.80%)
USD |
NASDAQ |
Feb 20, 16:00
13.56
+0.01
(+0.07%)
After-Hours: 20:00
Vor Biopharma Total Assets (Quarterly) : 176.24M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| iBio, Inc. | 64.39M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Senti Biosciences, Inc. | 52.68M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.402B |
| Shareholders Equity (Quarterly) | -2.225B |
| Debt to Equity Ratio | -0.0014 |
| Current Ratio | 9.156 |
| Net Debt Paydown Yield | 1.85% |